ZyVersa Therapeutics, Inc. short interest in 2024
In 2024, ZyVersa Therapeutics, Inc.'s disclosed short interest ran from 7.64% of shares outstanding on 28 Mar 2024 to 0.85% on 31 Dec 2024, a change of -6.79 percentage points. The year's high was 7.64% on 28 Mar 2024 and its low 0.85% on 31 Dec 2024, averaging 3.06% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.42 days on 15 Apr 2024. Full history: ZyVersa Therapeutics, Inc..
Cite this page
2024 in figures
- Start of year
- 7.64% (28 Mar 2024)
- End of year
- 0.85% (31 Dec 2024)
- Change
- -6.79 pp
- High
- 7.64% (28 Mar 2024)
- Low
- 0.85% (31 Dec 2024)
- Average
- 3.06%
- Highest days to cover
- 1.42 (15 Apr 2024)
- SEC filings marked
- 5
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 28 Mar 2024 | 7.64% | 1.00 | 10-K filed |
| 15 Apr 2024 | 6.07% | 1.42 | |
| 15 Aug 2024 | 3.97% | 1.00 | 10-Q filed, 10-Q filed |
| 30 Aug 2024 | 4.82% | 1.00 | |
| 30 Sep 2024 | 2.32% | 1.00 | |
| 15 Oct 2024 | 0.94% | 1.00 | |
| 15 Nov 2024 | 1.23% | 1.00 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 1.66% | 1.00 | |
| 13 Dec 2024 | 1.09% | 1.00 | |
| 31 Dec 2024 | 0.85% | 1.00 |
See also: ZyVersa Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.